ABSI
Absci Corporation
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
9.60
▲ 0.32 (3.45%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
9.22
Prev close
9.28
Day high
9.90
Day low
9.50
Volume
2.33M
Market cap
$1.64B
P/E (TTM)
—
52W range
2.24 – 12.06
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
20.33M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 30, 26 | SZELA MARY T. Director |
BUY | 12.90K | $148.87K | Direct |
| Jun 4, 26 | SIROSH JOSEPH Director |
STOCK | 10.10K | $0 | Direct |
| Jun 4, 26 | MCGINNIS KAREN K Director |
STOCK | 10.10K | $0 | Direct |
| Jun 4, 26 | RABINOVITSJ DANIEL A Director |
STOCK | 10.10K | $0 | Direct |
| Jun 4, 26 | SZELA MARY T. Director |
STOCK | 10.10K | $0 | Direct |
| Jun 4, 26 | SZELA MARY T. Director |
STOCK | 8.40K | $0 | Direct |
| Jun 4, 26 | VAN HOUTEN FRANS Director |
STOCK | 10.10K | $0 | Direct |
| Jun 4, 26 | PANGALOS MENELAS N Director |
STOCK | 10.10K | $0 | Direct |
| May 13, 26 | PANGALOS MENELAS N Director |
BUY | 37.45K | $200.75K | Direct |
| Mar 12, 26 | BUSCH ANDREAS Officer |
BUY | 100.00K | $229.00K | Direct |
| Mar 2, 26 | MCCLAIN SEAN Chief Executive Officer |
STOCK | 406.20K | $0 | Direct |
| Mar 2, 26 | MCCLAIN SEAN Chief Executive Officer |
STOCK | 406.20K | $0 | Direct |
| Mar 2, 26 | BEDRICK TODD Officer |
STOCK | 49.60K | $0 | Direct |
| Mar 2, 26 | BEDRICK TODD Officer |
STOCK | 49.60K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BEDRICK TODD |
Officer | 216.94K | Stock Award(Grant) |
BUSCH ANDREAS |
Officer | 421.45K | Purchase |
JONASSON ZACHARIAH |
Chief Financial Officer | 499.78K | Stock Award(Grant) |
MCCLAIN SEAN |
Chief Executive Officer | 8.72M | Stock Award(Grant) |
MCGINNIS KAREN K |
Director | 48.42K | Stock Award(Grant) |
PANGALOS MENELAS N |
Director | 242.41K | Stock Award(Grant) |
RABINOVITSJ DANIEL A |
Director | 33.42K | Stock Award(Grant) |
SIROSH JOSEPH |
Director | 33.42K | Stock Award(Grant) |
VAN HOUTEN FRANS |
Director | 73.42K | Stock Award(Grant) |
WALKER SHELBY J |
Officer | 139.78K | Stock Award(Grant) |
Unusual options activity
Flagged1
Total notional$805.18K
Call notional$805.18K
Put notional$0
Tiltcall-weighted
Likely opening0 of 1
| Side | Strike | Expiry | Volume | Open int. | Vol / OI | Notional | IV | Score | |
|---|---|---|---|---|---|---|---|---|---|
| CALL | 4.00 | Nov 20, 26 89d |
1.69K | 1.79K | 0.9× | $805.18K | 127% | at bid | 56 |
How this is calculated, and what it cannot see
A contract is flagged when today's volume approaches or exceeds its open interest, the position is worth at least $40,000, and at least 150 contracts changed hands. Open interest is what was outstanding at yesterday's close, so volume above it means the flow cannot all be closing — something is being opened.
The score weights four things: volume against open interest, dollar notional, volume against the rest of that chain, and where the last print sat inside the bid/ask spread.
What it cannot see. Volume here is a daily total, so ten small orders and one large one are indistinguishable — this is not block or sweep detection, which needs exchange-level time and sales. The print column compares the last trade to the current quote, which is a proxy for who was the aggressor, not a tagged flag. Quotes are delayed. A single large trade can be a hedge, a roll, or one leg of a spread, and none of those mean what a naked directional bet would mean.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.52
Call-heavy session
Put / call open interest
0.36
Positioning, not flow
Max pain
9.00
-5.8% from spot
ATM implied vol
96.1%
Nearest strike to spot
Skew (10% OTM)
+15.6%
Puts bid over calls
Call volume
340
Contracts, this expiry
Put volume
178
Contracts, this expiry
Heaviest call OI
10.00
902 contracts
Heaviest put OI
9.00
345 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+4.03%
+5.4%
1M
+18.34%
+14.6%
3M
+87.62%
+84.5%
6M
+260.38%
+249.3%
YTD
+173.64%
+161.4%
1Y
+271.60%
+251.6%
3Y
+496.88%
+422.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$1.64B
Enterprise value$1.44B
Revenue (TTM)$1.56M
Gross profit$-84.23M
EBITDA$-119.51M
Net income$-121.08M
EPS (TTM)$-0.79
Free cash flow$-50.59M
Total cash$201.14M
Total debt$3.83M
Book value / share$1.44
Shares outstanding171.61M
Float163.81M
Short % of float26.87%
Dividend yield—
Beta (5Y)2.43
Short interest
Shares short
37.31M
Prior 36.94M
Change vs prior
+1.0%
Shorts adding
% of float
26.87%
Heavily shorted
% of shares out
22.02%
Against total outstanding
Days to cover
9.5
Crowded exit
Float
163.81M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E—
Forward P/E-14.14
PEG ratio—
Price / sales—
Price / book6.66
EV / revenue923.51
EV / EBITDA-12.06
Gross margin0.00%
Operating margin-10741.51%
Profit margin0.00%
Return on equity-57.72%
Return on assets-34.09%
Debt / equity1.56
Current ratio10.63
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.80M | $4.53M | $5.72M | $5.75M | -38.2% |
| Operating revenue | $2.80M | $4.53M | $5.72M | $5.75M | -38.2% |
| Research & development | $81.42M | $63.86M | $48.07M | $58.91M | +27.5% |
| Selling, general & admin | $35.06M | $36.17M | $37.83M | $40.55M | -3.1% |
| Total operating expense | $128.22M | $113.42M | $99.90M | $112.50M | +13.0% |
| Operating income | -$125.42M | -$108.89M | -$94.18M | -$106.75M | -15.2% |
| Net interest income | -$209.00K | -$565.00K | -$1.01M | -$972.00K | +63.0% |
| Pre-tax income | -$115.11M | -$103.04M | -$110.47M | -$105.36M | -11.7% |
| Tax provision | $69.00K | $70.00K | $100.00K | -$461.00K | -1.4% |
| Net income | -$115.18M | -$103.11M | -$110.57M | -$104.90M | -11.7% |
| Net income to common | -$115.18M | -$103.11M | -$110.57M | -$104.90M | -11.7% |
| Basic EPS | -0.84 | -0.94 | -1.20 | -1.15 | +10.6% |
| Diluted EPS | -0.84 | -0.94 | -1.20 | -1.15 | +10.6% |
| EBIT | -$114.91M | -$102.47M | -$109.46M | -$104.39M | -12.1% |
| EBITDA | -$103.16M | -$89.08M | -$95.46M | -$91.29M | -15.8% |
| Basic shares | 136.78M | 110.24M | 92.03M | 90.85M | +24.1% |
| Diluted shares | 136.78M | 110.24M | 92.03M | 90.85M | +24.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.02M | $41.21M | $72.36M | $59.95M | — | -51.4% |
| Cash & short-term investments | $144.29M | $112.42M | $97.66M | $164.43M | — | +28.3% |
| Accounts receivable | — | $0 | $2.19M | — | — | — |
| Total current assets | $149.57M | $133.83M | $120.58M | $186.86M | — | +11.8% |
| Property, plant & equipment | $23.77M | $33.13M | $45.82M | $58.04M | — | -28.3% |
| Goodwill & intangibles | $41.51M | $44.88M | $48.25M | $72.96M | — | -7.5% |
| Total assets | $216.30M | $213.61M | $217.30M | $321.01M | — | +1.3% |
| Total current liabilities | $22.77M | $28.66M | $29.56M | $30.27M | — | -20.6% |
| Current debt | $873.00K | $2.73M | $3.26M | $2.95M | — | -68.1% |
| Long-term debt | — | $1.26M | $4.66M | $7.98M | $1.12M | — |
| Total debt | $5.30M | $10.03M | $15.88M | $22.98M | — | -47.1% |
| Total liabilities | $26.85M | $34.48M | $41.12M | $46.59M | — | -22.1% |
| Retained earnings | -$624.78M | -$509.60M | -$406.50M | -$295.93M | — | -22.6% |
| Shareholder equity | $189.45M | $179.13M | $176.18M | $274.41M | — | +5.8% |
| Working capital | $126.81M | $105.17M | $91.02M | $156.59M | — | +20.6% |
| Net tangible assets | $147.94M | $134.25M | $127.92M | $201.46M | — | +10.2% |
| Shares issued | 151.52M | 115.36M | 93.09M | 92.41M | — | +31.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$115.18M | -$103.11M | -$110.57M | -$104.90M | -11.7% |
| Depreciation & amortisation | $11.74M | $13.39M | $14.00M | $13.10M | -12.3% |
| Stock-based compensation | $18.32M | $19.45M | $11.42M | $12.54M | -5.8% |
| Change in working capital | $423.00K | -$368.00K | $1.52M | -$1.54M | +214.9% |
| Operating cash flow | -$92.92M | -$72.40M | -$64.64M | -$81.34M | -28.3% |
| Capital expenditure | -$1.11M | -$404.00K | -$860.00K | -$16.18M | -174.0% |
| Investing cash flow | -$50.16M | -$41.58M | $81.94M | -$126.98M | -20.6% |
| Financing cash flow | $105.95M | $82.53M | -$4.48M | $5.24M | +28.4% |
| Free cash flow | -$94.03M | -$72.81M | -$65.50M | -$97.51M | -29.2% |
| End cash position | $21.08M | $58.21M | $89.67M | $76.84M | -63.8% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $215.00K | $650.00K | $378.00K | $593.00K | $1.18M | -66.9% |
| Operating revenue | $215.00K | $650.00K | $378.00K | $593.00K | $1.18M | -66.9% |
| Research & development | $19.27M | $25.35M | $19.25M | $20.46M | $16.36M | -24.0% |
| Selling, general & admin | $9.06M | $8.62M | $8.44M | $8.53M | $9.47M | +5.1% |
| Total operating expense | $31.06M | $36.79M | $30.53M | $31.99M | $28.91M | -15.6% |
| Operating income | -$30.85M | -$36.14M | -$30.15M | -$31.39M | -$27.73M | +14.7% |
| Net interest income | -$18.00K | -$29.00K | -$45.00K | -$56.00K | -$79.00K | +37.9% |
| Pre-tax income | -$29.58M | -$29.72M | -$28.60M | -$30.44M | -$26.35M | +0.5% |
| Tax provision | $18.00K | -$162.00K | $104.00K | $131.00K | -$4.00K | +111.1% |
| Net income | -$29.60M | -$29.56M | -$28.71M | -$30.57M | -$26.35M | -0.1% |
| Net income to common | -$29.60M | -$29.56M | -$28.71M | -$30.57M | -$26.35M | -0.1% |
| Basic EPS | -0.19 | -0.20 | -0.20 | -0.24 | -0.21 | +5.0% |
| Diluted EPS | -0.19 | -0.20 | -0.20 | -0.24 | -0.21 | +5.0% |
| EBIT | -$29.56M | -$29.70M | -$28.56M | -$30.38M | -$26.27M | +0.4% |
| EBITDA | -$26.84M | -$26.87M | -$25.71M | -$27.38M | -$23.20M | +0.1% |
| Basic shares | 152.96M | 150.61M | 143.77M | 127.59M | 124.46M | +1.6% |
| Diluted shares | 152.96M | 150.61M | 143.77M | 127.59M | 124.46M | +1.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8.63M | $20.02M | $9.48M | $38.02M | $46.99M | — | -56.9% |
| Cash & short-term investments | $125.70M | $144.29M | $152.47M | $117.46M | $133.98M | — | -12.9% |
| Accounts receivable | — | — | $1.00M | $700.00K | $1.38M | $0 | — |
| Total current assets | $131.97M | $149.57M | $174.99M | $137.40M | $155.98M | — | -11.8% |
| Property, plant & equipment | $21.41M | $23.77M | $26.21M | $27.52M | $30.74M | — | -10.0% |
| Goodwill & intangibles | $40.77M | $41.51M | $42.36M | $43.20M | $44.04M | — | -1.8% |
| Total assets | $195.59M | $216.30M | $244.99M | $209.89M | $232.45M | — | -9.6% |
| Total current liabilities | $20.03M | $22.77M | $29.71M | $31.32M | $27.28M | — | -12.0% |
| Current debt | $413.00K | $873.00K | $1.31M | $1.99M | $2.54M | — | -52.7% |
| Long-term debt | — | — | $65.00K | $161.00K | $682.00K | $1.26M | — |
| Total debt | $4.42M | $5.30M | $6.22M | $7.41M | $8.92M | — | -16.7% |
| Total liabilities | $23.62M | $26.85M | $34.65M | $36.52M | $33.65M | — | -12.0% |
| Retained earnings | -$654.38M | -$624.78M | -$595.22M | -$566.52M | -$535.95M | — | -4.7% |
| Shareholder equity | $171.97M | $189.45M | $210.34M | $173.37M | $198.80M | — | -9.2% |
| Working capital | $111.94M | $126.81M | $145.29M | $106.08M | $128.70M | — | -11.7% |
| Net tangible assets | $131.20M | $147.94M | $167.98M | $130.18M | $154.75M | — | -11.3% |
| Shares issued | 155.35M | 151.52M | 149.75M | 127.68M | 127.54M | — | +2.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$29.60M | -$29.56M | -$28.71M | -$30.57M | -$26.35M | — | -0.1% |
| Depreciation & amortisation | $2.73M | $2.83M | $2.84M | $3.00M | $3.07M | — | -3.5% |
| Stock-based compensation | $4.38M | $4.26M | $4.40M | $4.75M | $4.91M | — | +2.9% |
| Change in working capital | -$3.13M | -$801.00K | -$2.73M | $6.74M | -$2.79M | — | -290.5% |
| Operating cash flow | -$26.31M | -$29.18M | -$25.03M | -$16.87M | -$21.84M | — | +9.9% |
| Capital expenditure | -$30.00K | — | -$962.00K | -$223.00K | -$25.00K | -$23.00K | — |
| Investing cash flow | $7.36M | $19.55M | -$63.70M | $9.04M | -$15.04M | — | -62.3% |
| Financing cash flow | $7.56M | $3.84M | $60.32M | -$1.00M | $42.79M | — | +96.7% |
| Free cash flow | -$26.34M | -$29.08M | -$25.99M | -$17.10M | -$21.86M | — | +9.4% |
| End cash position | $9.69M | $21.08M | $26.87M | $55.29M | $64.13M | — | -54.0% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.20 | -0.21 | -6.4% |
| Dec 2025 | -0.17 | -0.23 | -32.5% |
| Sep 2025 | -0.22 | -0.20 | +7.4% |
| Jun 2025 | -0.21 | -0.24 | -15.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.20 | 8 | $931.67K | +57.1% |
| Next quarter | -0.20 | 7 | $1.12M | +72.3% |
| Current year | -0.81 | 7 | $3.84M | +37.1% |
| Next year | -0.68 | 7 | $16.15M | +320.5% |
Analyst targets & ownership
Mean target$13.89
High target$17.00
Low target$10.00
Implied upside44.68%
Analyst count9
ConsensusSTRONG BUY
Strong buy / Buy2 / 7
Hold1
Sell / Strong sell0 / 0
Held by insiders11.85%
Held by institutions87.07%
Institutions holding257
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 26 | Needham | MAINTAINED | Buy | Buy |
| Aug 12, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 2, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jun 25, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 24, 26 | Needham | MAINTAINED | Buy | Buy |
| Jun 24, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 15, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jun 4, 26 | Leerink Partners | INITIATED | — | Outperform |
| May 28, 26 | BTIG | INITIATED | — | Buy |
| May 8, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Mar 30, 26 | Needham | MAINTAINED | Buy | Buy |
| Mar 25, 26 | Needham | MAINTAINED | Buy | Buy |
Moving averages & technicals
SMA 10
9.35
+2.71% from price
SMA 20
8.63
+10.71% from price
SMA 50
9.01
+6.00% from price
SMA 100
6.91
+39.00% from price
SMA 200
4.99
+91.38% from price
EMA 12
9.18
+4.60% from price
EMA 26
8.93
+7.54% from price
EMA 50
8.45
+13.54% from price
RSI (14)
56.6
Neutral
MACD (12,26,9)
0.25
Hist 0.10
ATR (14)
0.65
6.85% of price
Realised vol 30D
86.6%
Annualised
Bollinger upper
10.35
20, 2σ
Bollinger lower
6.90
20, 2σ
50 / 200 cross
Golden
9.01 vs 4.99
Trend bias
Above 200
+91.38%
Risk profile
Beta vs SPY
3.37
More volatile than market
Correlation to SPY
0.41
Loosely linked
Realised vol 30D
86.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-54.0%
Peak to trough
Max drawdown 5Y
-94.9%
Peak to trough
ATR 14
0.65
6.85% of price
Beta (reported)
2.43
5Y monthly, from filing
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-11
Corporate Changes & Voting Matters
8-K · 2026-06-24
Corporate Changes & Voting Matters
8-K · 2026-06-05
Corporate Changes & Voting Matters
8-K · 2026-05-07
Proxy Statements
DEF 14A · 2026-04-22
Offering Registrations
S-8 · 2026-03-24
Corporate Changes & Voting Matters
8-K · 2026-03-06
Corporate Changes & Voting Matters
8-K · 2026-01-14
Headlines
Absci (ABSI) Q2 2026 Earnings Call Transcript
Motley Fool · 3d ago
AMD’s $1.3 Billion Portfolio Reveals Its Biggest Investments and Where AI Demand Lands Next
24/7 Wall St. · 4d ago
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci
Zacks · 5d ago
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
Zacks · 5d ago
Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline Updates
MarketBeat · 6d ago
Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation
Simply Wall St. · 10d ago
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed?
Simply Wall St. · 11d ago
Absci Corporation Q2 2026 Earnings Call Summary
Moby · 11d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.